Structural MRI correlates of the MMSE and pentagon copying test in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 12, 2014, Pages 1405-1410

  Garcia Diaz, A I ^c   Segura, B ^b,c   Baggio, H C ^b,c   Marti, M J ^a,b   Valldeoriola, F ^a,b   Compta, Y ^a,b   Vendrell, P ^a,b,c   Bargallo, N ^a,b   Tolosa, E ^a,b   Junque, C ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cortical thickness; Global atrophy; Parkinson disease; Pentagon copying test; Screening test

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN LATERAL VENTRICLE; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DATA ANALYSIS SOFTWARE; EDUCATION; FEMALE; FUSIFORM GYRUS; GLOBAL ATROPHY; GRAY MATTER; HOEHN AND YAHR SCALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; ONSET AGE; PARKINSON DISEASE; PENTAGON COPYING TEST; POSTCENTRAL GYRUS; POSTERIOR CINGULATE; PRECUNEUS; PRIMARY MOTOR CORTEX; RELIABILITY; SCORING SYSTEM; SCREENING TEST; SUPERIOR PARIETAL LOBULE; SUPERIOR TEMPORAL GYRUS; SUPRAMARGINAL GYRUS; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 84915785519     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.10.014     Document Type: Article

References (30)

1. Williams-Gray C.H., Foltynie T., Brayne C.E., Robbins T.W., Barker R.A. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007, 130:1787-1798.
2. Litvan I., Aarsland D., Adler C.H., Goldman J.G., Kulisevsky J., Mollenhauer B., et al. MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011, 15(26):1814-1824.
3. Svenningsson P., Westman E., Ballard C., Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis biomarkers and treatment. Lancet Neurol 2012, 11:697-707.
4. Reginold W., Duff-Canning S., Meaney C., Armostrong M.J., Fox S., Rothberg B., et al. Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. Dement Geriatr Cogn Disord 2013, 36:67-75.
5. Aarsland D., Andersen K., Larsen J.P., Lolk A., Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson's disease: an 8-year prospective study. Arch Neurol 2003, 60:387-392.
6. Ismail Z., Rajji T.K., Shulman K.I. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 2010, 25:111-120.
7. Hoops S., Nazem S., Siderowf A.D., Duda J.E., Xie S.X., Stern M.B., et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson's disease. Neurology 2009, 24(73):1738-1745.
8. Dubois B., Burn D., Goetz C., Aarsland D., Brown R.G., Broe G.A., et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007, 22:2314-2324.
9. Williams-Gray C.H., Evans J.R., Goris A., Foltynie T., Ban M., Robbins T.W., et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009, 132:2958-2969.
10. Williams-Gray C.H., Mason S.L., Evans J.R., Foltynie T., Brayne C., Robbins T.W., et al. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. JNeurol Neurosurg Psychiatry 2013, 84:1258-1264.
11. Apostolova L., Alves G., Hwang K.S., Babakchanian S., Bronnick K.S., Larsen J.P., et al. Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment. Neurobiol Aging 2012, 33:2113-2124.
12. Summerfield C., Junque C., Tolosa E., Salgado-Pineda P., Gómez-Anson B., Martí M.J., et al. Structural brain changes in Parkinson's disease with dementia: a voxel-based morphometry study. Arch Neurol 2005, 62:281-285.
13. Zarei M., Ibarretxe-Bilbao N., Compta Y., Hough Y., Junque C., Bargallo N., et al. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. JNeurol Neurosurg Psychiatry 2013, 84:875-881.
14. Filoteo J.V., Reed J.D., Litvan I., Harrington D.L. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease. Mov Disord 2014, 3:360-367.
15. Daniel S.E., Lees A.J. Parkinson's disease society brain bank, London: overview and research. JNeural Transm Suppl 1993, 39:165-172.
16. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2653.
17. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
18. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U. S. A 2000, 97:11050-11055.
19. Sled J.G., Zijdenbos A.P., Evans A.C. Anonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998, 17:87-97.
20. Ségonne F., Pacheco J., Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 2007, 26:518-529.
21. Hagler D.J., Saygin A.P., Sereno M.I. Smoothing and cluster thresholding for corticals urface-based group analysis of fMRI data. Neuroimage 2006, 33:1093-1103.
22. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
23. Apostolova L.G., Lu P.H., Rogers S., Dutton R.A., Hayashi K.M., Toga A.W., et al. 3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord 2006, 20:224-231.
24. Compta Y., Parkkinen L., O'Sullivan S.S., Vandrovcova J., Holton J.L., Collins C., et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?. Brain 2011, 134:1493-1505.
25. Pereira J.B., Junque C., Marti M.-J., Ramirez-Ruiz B., Bargallo N., Tolosa E. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009, 24:1193-1199.
26. Pagonabarraga J., Corcuera-Solano I., Vives-Gilabert Y., Llebaria G., Garcia-Sanchez C., Pascual-Sedano B., et al. Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease. PLoS One 2013, 8(1):e54980.
27. Lüsebrink F., Wollrab A., Speck O. Cortical thickness determination of the human brain using high resolution 3 T and 7 T MRI data. NeuroImage 2013, 70:122-131.
28. Pereira J.B., Ibarretxe-Bilbao N., Marti M.J., Compta Y., Junque C., Bargallo N., et al. Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical Folding, and cortical thickness. Hum Brain Mapp 2012, 33:2521-2534.
29. Ala T.A., Hughes L.F., Kyrouac G.A., Ghobrial M.W., Elble R.J. Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease. JNeurol Neurosurg Psychiatry 2001, 70:483-488.
30. Hanganu A., Bedetti C., Degroot C., Mejia-Constain B., Lafontaine A.L., Soland V., et al. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally. Brain 2014, 137:1120-1129.